Dermapharm Holding SE (ETR:DMP)
Germany · Delayed Price · Currency is EUR 40.30
+0.25 (0.62%)
Aug 19, 2026, 5:35 PM CET
Dermapharm Holding SE Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,996 | 2,119 | 2,094 | 2,280 | 2,020 | 4,808 | |
Market Cap Growth | 13.40% | 1.16% | -8.13% | 12.85% | -57.98% | 56.78% |
Enterprise Value | 2,806 | 2,980 | 3,007 | 3,258 | 2,493 | 5,294 |
Last Close Price | 40.30 | 38.62 | 37.19 | 39.51 | 34.23 | 77.84 |
PE Ratio | 15.04 | 16.00 | 18.41 | 36.55 | 15.05 | 22.94 |
Forward PE | 14.90 | 15.94 | 16.66 | 17.44 | 10.61 | 22.27 |
PS Ratio | 1.69 | 1.80 | 1.75 | 1.98 | 1.94 | 5.01 |
PB Ratio | 2.72 | 3.07 | 3.44 | 4.18 | 3.79 | 9.62 |
P/TBV Ratio | - | - | - | - | 41.96 | 310.95 |
P/FCF Ratio | 8.29 | 11.33 | 12.84 | 12.82 | 8.10 | 25.42 |
P/OCF Ratio | 7.01 | 9.25 | 10.40 | 10.39 | 7.00 | 19.20 |
PEG Ratio | 1.66 | 1.77 | 0.54 | 1.22 | 1.22 | 1.22 |
EV/Sales Ratio | 2.37 | 2.53 | 2.52 | 2.83 | 2.40 | 5.51 |
EV/EBITDA Ratio | 9.92 | 11.26 | 11.99 | 14.79 | 8.24 | 16.95 |
EV/EBIT Ratio | 11.36 | 12.59 | 13.54 | 16.87 | 8.82 | 17.89 |
EV/FCF Ratio | 11.65 | 15.93 | 18.43 | 18.31 | 9.99 | 27.98 |
Debt / Equity Ratio | 1.41 | 1.53 | 1.63 | 2.01 | 0.97 | 1.16 |
Debt / EBITDA Ratio | 3.73 | 3.89 | 3.85 | 4.83 | 1.69 | 1.83 |
Debt / FCF Ratio | 4.32 | 5.66 | 6.07 | 6.15 | 2.07 | 3.07 |
Net Debt / Equity Ratio | 1.11 | 1.24 | 1.43 | 1.71 | 0.68 | 0.84 |
Net Debt / EBITDA Ratio | 3.00 | 3.22 | 3.46 | 4.24 | 1.20 | 1.34 |
Net Debt / FCF Ratio | 3.38 | 4.56 | 5.32 | 5.25 | 1.46 | 2.21 |
Asset Turnover | 0.54 | 0.55 | 0.56 | 0.64 | 0.74 | 0.73 |
Inventory Turnover | 1.15 | 1.23 | 1.34 | 1.55 | 1.57 | 1.56 |
Quick Ratio | 0.93 | 0.95 | 0.72 | 0.75 | 1.18 | 1.61 |
Current Ratio | 2.00 | 2.05 | 1.82 | 1.60 | 2.45 | 3.34 |
Return on Equity (ROE) | 20.80% | 20.22% | 19.38% | 11.24% | 25.69% | 50.68% |
Return on Assets (ROA) | 6.93% | 6.93% | 6.55% | 6.76% | 12.53% | 14.06% |
Return on Invested Capital (ROIC) | 11.52% | 11.21% | 9.76% | 9.29% | 19.12% | 24.46% |
Return on Capital Employed (ROCE) | 12.90% | 12.80% | 12.70% | 10.90% | 23.70% | 23.60% |
Earnings Yield | 7.22% | 6.25% | 5.43% | 2.74% | 6.64% | 4.36% |
FCF Yield | 12.06% | 8.83% | 7.79% | 7.80% | 12.35% | 3.93% |
Dividend Yield | 2.20% | 2.28% | 2.42% | 2.23% | 3.07% | 2.79% |
Payout Ratio | 33.60% | 36.59% | 41.64% | 90.64% | 87.04% | 22.61% |
Total Shareholder Return | 2.24% | 2.28% | 2.42% | 2.23% | 3.07% | 2.79% |